2019 Canadian Election: Cannabis Fatigue

Stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) have soared since the 2015 election, but 2019 is shaping up to be largely irrelevant for the young sector.

Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis was the hot topic in the 2015 election. Legal weed garnered Canada global attention and ignited an even more rigorous debate over how the industry would be structured and regulated after the Liberal victory. The push for legal weed was hugely consequential for investors and sparked a gold rush in the fledgling sector.

Canada finally crossed the finish line in October 2018 and legalized recreational cannabis. Later this month I will discuss the successes and failures of legalization so far, but today we are going to focus on the impacts this election could have on cannabis stocks.

Canopy Growth stock was priced below the $2 mark in the week before the 2015 Canadian election. As of close on October 4, it was priced at $30.51 and boasted a market cap above $10 billion. Still, it has been a bumpy ride for Canopy Growth since late April.

Analysts had warned of weak earnings for top producers like Canopy and Aurora Cannabis ahead of the spring and summer. Aurora failed to achieve profitability in its most recent earnings report and partly blamed the slow retail rollout in Ontario and other Canadian provinces. The news was worse for Canopy, which said in August that it would need another three to five years to turn a profit. Fortunately, Canopy boasts a multi-billion-dollar war chest and a heavyweight backer in the form of Constellation Brands.

Canada is set to legalize edibles, vape pens, and other products that will allow Canopy and other cannabis companies to move forward with a plethora of product launches. This next round of legalization is being called “Cannabis 2.0.” Canopy has a large stable of products that it intends to launch before the New Year.

Most parties are mum on marijuana

Many of the top major parties have failed to chime in on cannabis. The Conservatives, who opposed recreational cannabis legalization in 2015, have made it clear that they do not intend to revisit the issue in the future. The party has not brought forth any specific proposals on the issue.

The Bloc Quebecois, the New Democratic Party (NDP), and the People’s Party of Canada have also failed to release any specific proposals on cannabis. The Green Party has vowed to introduce measures that aim to remove obstacles to cannabis production and sales. This would include lowering the federal price for cannabis to compete with a resurgent black market, removing the sales tax on medical cannabis, and imposing organic production standards.

As we have already gone over, the Liberals plans to legalize edibles, extracts, and topical products by October 17. These products are expected to hit shelves by the middle of December.

Cannabis stocks ahead of the election

Horizons Marijuana Life Sciences ETF, which seeks the replicate the North American Marijuana Index, has dropped 32% over the past three months. Where the 2015 election was huge for the cannabis sector, this one is shaping up to be almost entirely inconsequential. Cannabis investors should instead focus their attention on “Cannabis 2.0” and look to jump on value ahead of the next batch of product launches.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »